HomeInfo CentreNewsSkin Cancer Drug Trial Shows Positive Results

Skin Cancer Drug Trial Shows Positive Results

  • May 15, 2013
  • Posted by: Spotscreen
  • Category: News
No Comments

A new drug treatment for basal cell carcinoma was recently trialed with encouraging results. The treatment, known as Dz13, targets the “c-jun” gene which is known to be responsible for triggering basal cell carcinoma – the most common type of skin cancer.

The drug treatment which was trialled on a human being, showed signs of reducing the tumor by getting the body’s natural immune system to start combating the tumor. Read More Here.



Author: Spotscreen
Spotscreen is Australia’s leading onsite skin cancer screening and corporate health provider, focussing on providing the highest quality of specialised onsite health programs for your workplace and local community.